ADC Therapeutics SA
Change company Symbol lookup
Select an option...
ADCT ADC Therapeutics SA
ALTR Altair Engineering Inc
CVX Chevron Corp
ASCB ASPAC II Acquisition Corp
STRS Stratus Properties Inc
ESMC Escalon Medical Corp
ATO Atmos Energy Corp
LVS Las Vegas Sands Corp
HUBB Hubbell Inc
PM Philip Morris International Inc
Go

Health Care : Biotechnology | Small Cap Blend
Based in Switzerland
Company profile

ADC Therapeutics SA is a Switzerland-based clinical-stage oncology drug discovery and development company. It develops antibody drug conjugates (ADCs) for the treatment of both solid and hematological cancers. It employs monoclonal antibodies specific to particular tumor antigens conjugated to a class of pyrrolobenzodiazepine (PBD)-based warheads to selectively target and kill cancer cells. The Company has multiple PBD-based ADCs in ongoing clinical trials, ranging from first in human to pivotal Phase II clinical trials, and numerous preclinical ADCs in development. Its main drug candidates are ADCT-301 for the treatment of lymphoma and leukemia and ADCT-402 for the treatment of non-Hodgkin’s lymphoma and B-cell leukemia. It serves customers in the United States, Switzerland, and the United Kingdom.

Closing Price
$4.82
Day's Change
-0.07 (-1.43%)
Bid
--
Ask
--
B/A Size
--
Day's High
5.16
Day's Low
4.82
Volume
(Light)
Volume:
176,916

10-day average volume:
231,023
176,916

Salesforce Inc., Microsoft Share Losses Lead Dow's 100-point Fall

2:59 pm ET September 15, 2022 (MarketWatch)
Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Behind losses for shares of Salesforce Inc. and Microsoft, the Dow Jones Industrial Average is falling Thursday afternoon. The Dow was most recently trading 107 points (0.3%) lower, as shares of Salesforce Inc. (CRM) and Microsoft (MSFT) are contributing to the blue-chip gauge's intraday decline. Salesforce Inc.'s shares have fallen $4.47 (2.8%) while those of Microsoft have dropped $6.64, or 2.6%, combining for an approximately 73-point drag on the Dow. Other components contributing significantly to the decline include Visa (V), Apple Inc. (AAPL), and Chevron (CVX). A $1 move in any of the index's 30 components results in a 6.59-point swing.

Data source: Dow Jones Market Data, FactSet. Data compiled September 15, 2022.

	

(END) Dow Jones Newswires

September 15, 2022 14:59 ET (18:59 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.